866-997-4948(US-Canada Toll Free)

United States Stem Cell UCB Market Report 2017

Published By :

QYResearch

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 109 Pages

Notes:
Sales, means the sales volume of Stem Cell UCB
Revenue, means the sales value of Stem Cell UCB

This report studies sales (consumption) of Stem Cell UCB in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Caladrius Biosciences?
Celgene?
Mesoblast?
Pluristem Therapeutics
Athersys
CHA Bio & Diostech?
Cytori Therapeutics
Nuo Therapeutics?
Ocata Therapeutics?
Opexa Therapeutics?
Osiris Therapeutics?
Teva Pharmaceuticals?
United Therapeutics?

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Public cord blood banks
Private cord blood banks
Public Vs. Private UCB banks
Split by applications, this report focuses on sales, market share and growth rate of Stem Cell UCB in each application, can be divided into
Therapeutics service companies
Private and government research institutes
Academic Institutes
Research based pharmaceutical companies
Public and Private cord blood banks

Table of Contents

United States Stem Cell UCB Market Report 2017
1 Stem Cell UCB Overview
1.1 Product Overview and Scope of Stem Cell UCB
1.2 Classification of Stem Cell UCB
1.2.1 Public cord blood banks
1.2.2 Private cord blood banks
1.2.3 Public Vs. Private UCB banks
1.3 Application of Stem Cell UCB
1.3.1 Therapeutics service companies
1.3.2 Private and government research institutes
1.3.3 Academic Institutes
1.3.4 Research based pharmaceutical companies
1.3.5 Public and Private cord blood banks
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Stem Cell UCB (2011-2021)
1.4.1 United States Stem Cell UCB Sales and Growth Rate (2011-2021)
1.4.2 United States Stem Cell UCB Revenue and Growth Rate (2011-2021)

2 United States Stem Cell UCB Competition by Manufacturers
2.1 United States Stem Cell UCB Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Stem Cell UCB Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Stem Cell UCB Average Price by Manufactures (2015 and 2016)
2.4 Stem Cell UCB Market Competitive Situation and Trends
2.4.1 Stem Cell UCB Market Concentration Rate
2.4.2 Stem Cell UCB Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Stem Cell UCB Sales (Volume) and Revenue (Value) by States (2011-2016)
3.1 United States Stem Cell UCB Sales and Market Share by States (2011-2016)
3.2 United States Stem Cell UCB Revenue and Market Share by States (2011-2016)
3.3 United States Stem Cell UCB Price by States (2011-2016)

4 United States Stem Cell UCB Sales (Volume) and Revenue (Value) by Type (2011-2016)
4.1 United States Stem Cell UCB Sales and Market Share by Type (2011-2016)
4.2 United States Stem Cell UCB Revenue and Market Share by Type (2011-2016)
4.3 United States Stem Cell UCB Price by Type (2011-2016)
4.4 United States Stem Cell UCB Sales Growth Rate by Type (2011-2016)

5 United States Stem Cell UCB Sales (Volume) by Application (2011-2016)
5.1 United States Stem Cell UCB Sales and Market Share by Application (2011-2016)
5.2 United States Stem Cell UCB Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 United States Stem Cell UCB Manufacturers Profiles/Analysis
6.1 Caladrius Biosciences?
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Stem Cell UCB Product Type, Application and Specification
6.1.2.1 Public cord blood banks
6.1.2.2 Private cord blood banks
6.1.3 Caladrius Biosciences? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
6.1.4 Main Business/Business Overview
6.2 Celgene?
6.2.2 Stem Cell UCB Product Type, Application and Specification
6.2.2.1 Public cord blood banks
6.2.2.2 Private cord blood banks
6.2.3 Celgene? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
6.2.4 Main Business/Business Overview
6.3 Mesoblast?
6.3.2 Stem Cell UCB Product Type, Application and Specification
6.3.2.1 Public cord blood banks
6.3.2.2 Private cord blood banks
6.3.3 Mesoblast? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
6.3.4 Main Business/Business Overview
6.4 Pluristem Therapeutics
6.4.2 Stem Cell UCB Product Type, Application and Specification
6.4.2.1 Public cord blood banks
6.4.2.2 Private cord blood banks
6.4.3 Pluristem Therapeutics Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
6.4.4 Main Business/Business Overview
6.5 Athersys
6.5.2 Stem Cell UCB Product Type, Application and Specification
6.5.2.1 Public cord blood banks
6.5.2.2 Private cord blood banks
6.5.3 Athersys Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
6.5.4 Main Business/Business Overview
6.6 CHA Bio & Diostech?
6.6.2 Stem Cell UCB Product Type, Application and Specification
6.6.2.1 Public cord blood banks
6.6.2.2 Private cord blood banks
6.6.3 CHA Bio & Diostech? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
6.6.4 Main Business/Business Overview
6.7 Cytori Therapeutics
6.7.2 Stem Cell UCB Product Type, Application and Specification
6.7.2.1 Public cord blood banks
6.7.2.2 Private cord blood banks
6.7.3 Cytori Therapeutics Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
6.7.4 Main Business/Business Overview
6.8 Nuo Therapeutics?
6.8.2 Stem Cell UCB Product Type, Application and Specification
6.8.2.1 Public cord blood banks
6.8.2.2 Private cord blood banks
6.8.3 Nuo Therapeutics? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
6.8.4 Main Business/Business Overview
6.9 Ocata Therapeutics?
6.9.2 Stem Cell UCB Product Type, Application and Specification
6.9.2.1 Public cord blood banks
6.9.2.2 Private cord blood banks
6.9.3 Ocata Therapeutics? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
6.9.4 Main Business/Business Overview
6.10 Opexa Therapeutics?
6.10.2 Stem Cell UCB Product Type, Application and Specification
6.10.2.1 Public cord blood banks
6.10.2.2 Private cord blood banks
6.10.3 Opexa Therapeutics? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
6.10.4 Main Business/Business Overview
6.11 Osiris Therapeutics?
6.12 Teva Pharmaceuticals?
6.13 United Therapeutics?

7 Stem Cell UCB Manufacturing Cost Analysis
7.1 Stem Cell UCB Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Stem Cell UCB

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Stem Cell UCB Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Stem Cell UCB Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Stem Cell UCB Market Forecast (2016-2021)
11.1 United States Stem Cell UCB Sales, Revenue Forecast (2016-2021)
11.2 United States Stem Cell UCB Sales Forecast by Type (2016-2021)
11.3 United States Stem Cell UCB Sales Forecast by Application (2016-2021)
11.4 Stem Cell UCB Price Forecast (2016-2021)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *